Women have a larger and less atherogenic low density lipoprotein particle size than men

Atherosclerosis

Volumn 119, Issue 2, 1996, Pages 181-190

  Nikkilä, Matti ^a   Pitkäjärvi, Timo ^b   Koivula, Timo ^c   Solakivi, Tiina ^c,d   Lehtimäki, Terho ^c,d   Laippala, Pekka ^c   Jokela, Hannu ^c   Lehtomäki, Erkki ^b   Seppä, Kaija ^e   Sillanaukee, Pekka ^f  

^a Tampere City Hospital   (Finland)

^b City of Tampere   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e UNIVERSITY OF TAMPERE   (Finland)

^f NONE

Author keywords

Apolipoprotein E; Coronary artery disease; LDL size; Low density lipoprotein

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ADULT; AGE; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; PARTICLE SIZE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

EID: 0029671166     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05645-9     Document Type: Article

References (36)

1. Forette B, Tortrat D, Wolmark Y: Cholesterol as risk factor for mortality in elderly women. Lancet 1989;i:868.
2. Nikkilä M, Pitkäjärvi T, Koivula T, Lehtomäki E, Jokela H. Age-related changes and sex differences in serum lipid concentrations of health-screening subjects. Cardiovasc Risk Factors, 1991;1:204.
3. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. J Am Med Assoc 1982;248:1464.
4. Romm PA, Green CE, Reagan K, Rackley CE. Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease. Am J Cardiol 1991;67:479.
5. Coresh J, Kwiterovich PO Jr, Smith HH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res 1993;34:1687.
6. Campos H, Genest JJ, Blijlevens E. Low density lipoprotein particle size and coronary artery disease. Arteriosclerosis Thromb 1992;12:187.
7. Austin MA, King MC, Vranizian MA, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990;82:495.
8. Kwiterovich PO, Coresh J, Bachorik PS. The prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in premature coronary atherosclerosis. Am J Cardiol 1993;71:631.
9. Mahley RW, Innerarity TL. Lipoprotein receptors and cholesterol homeostasis. Biochem Biophys Acta, 1983;737:197.
10. Ehnholm C, Lukka M, Kuusi T, Nikkilä E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986;27:227.
11. Uterman G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987;1134:433.
12. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1.
13. Lippi U, Graziani MS, Manzato F. Assay of cholesterol in high density lipoprotein in hypertriglyceridemic sera. Clin Chem 1986;32:2118.
14. Nichols AV, Krauss RM, Musliner TA. Non-denaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol 1986;128:417.
15. Lehtimäki T, Moilanen T, Viikari J, Åkerblom H, Ehnholm C, Rönnemaa T, Marniemim J. Dahlen G, Nikkari T. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res 1990;31:487.
16. Heiss G, Tamir I, Davis C, Tyroler HA, Rifkind BM Schonfeld G, Jacobs D, Frantz ID Jr Lipoprotein -cholesterol distributions in selected North American populations: The Lipid Reserch Clinic's Program Prevalence Study. Circulation 1980;61:302-315.
17. Mann JI, Lewis B, Shepherd J. Winder AF, Fenster S Rose L, Morgan B. Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence and detection in Britain. Br Med J 1988;296:1702.
18. Simons LA. Interrelation of lipids and lipoproteins with coronary artery disease in 19 countries. Am J Cardiol 1986;57:5G.
19. Oliver MF. Might treatment of hypercholesterolaemia increase non-cardiac mortality? Lancet, 1991;337:1529.
20. La Rosa JC. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women? Women's Health Issues, 1992;2:102.
21. Hauner H, Stangl K, Burger K, Busch U, Blumer H Pfeiffer EF. Sex hormone concentrations in men with angiographically assessed coronary artery disease - relationship to obesity and body fat distribution. Klin Wochenschr, 1991;69:664.
22. Miller NE, Thelle DS, Förde OH, Mjös OD. The Tromsö Heart Study. High density lipoprotein and coronary heart disease: a case control study. Lancet 1977;i:965.
23. Manninen V, Tenkanen L, Koskinen P, Huttunen J Mänttäri M, Heinonen O, Frick H. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart risk in the Helsinki Heart Study. Circulation 1992;85:37.
24. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JB, Castelli WP, Knoke JD, Jacobs DR, Bangdiwala S, Tyroler AH. High density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8.
25. Assmann G, Schulte H, Funke H, von Eckardstein A Seedorf U. The prospective cardiovascular Munster (PROCAM) study: identification of high-risk individuals for myocardial infarction and the role of high-density lipoprotein. In: Miller NE. (ed). High Density Lipoproteins and Atherosclerosis II. Amsterdam: Excerpta Medica. ICS 826, 1989;51-65.
26. Castelli WP, Garrison RJ, Wilson PWF, Abbot ED Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoproteins levels. The Framingham Study. J Am Med Assoc 1986;256:2835.
27. McNamara JR, Campos H, Ordovas J, Peterson J, Wilson PWF. Schaefer EJ. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis 1987;7:483.
28. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP Jr, Mayer EJ, Krauss RM: LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 1993;88:381.
29. Dreon DM, Fernstrom HA, Miller B, Krauss RM. Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet. Arteriosclerosis Thromb Vasc Biol 1995;15:105.
30. Austin MA, King M-C, Vranizan KM, Newman B, Krauss RM. Inheritance of low density lipoprotein sub-class patterns: results of complex segregation analysis. Am J Hum Genet 1988;43:838.
31. Genest J Jr, McNamara JR, Ordovas JM, Jenner JL Silberman SR, Andersson KM, Wilson PWF, Salem DN, Schaefer EJ. Lipoprotein cholesterol, apolipoprotein Al and B lipoprotein(a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol 1992;19:792.
32. Croft KD, Dimmit SB, Moulton C, Beilin LJ. Low density lipoprotein composition and oxidizability in coronary disease - apparent favourable effect of beta blockers. Atherosclerosis 1992;97:123.
33. Stuyt PM, Brennikmeier BJ. Demacker PN. Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease. Scand J Clin Lab 1991;51:425.
34. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia and coronary heart disease. J Am Med Assoc 1994;272:1666.
35. Schaefer EJ, Lamon-Fava S, Johnson S, Ordovas JM Schaefer MM, Castelli WP, Wilson PWF. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study. Arteriosclerosis Thromb 1994;14:1105.
36. Zhao SP, Verhoeven J, Vink J, Hollaar L, van der Laarse A, de Knijff P, van Hooft FM. Relationship between apolipoprotein E and low density lipoprotein particle size. Atherosclerosis 1993;102:147.